| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142952 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142900 polypeptide with the transport function of herpesviral VP22 protein and which can regulate cell cycle progression, e.g. proteins which can induce apoptosis, or proteins which can arrest cells from the cell cycle to arrest cell proliferation |
| 07/22/2004 | US20040142882 Use of glycyrrhizin and its derivatives as RANTES inducers |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142873 peptide of sequence (Gly-Pro-Gln)n-NH2, wherein n ranges between 1 and 3; to enhance skin appearance |
| 07/22/2004 | US20040142854 internalization sequence covalently linked to the modulating agent, a liposome that encapsulates the modulating agent or an antibody or ligand that binds to a cell surface receptor; alopecia |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142335 Method for determining skin stress or skin ageing in vitro |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141973 IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141943 Novel cationic associative polyurethanes and their use |
| 07/22/2004 | US20040141939 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 07/22/2004 | US20040141938 Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract and the utilization of a hop extract or hop-malt extract for producing cosmetic and dermatological preparations for reducing the sebum contents of the skin |
| 07/22/2004 | US20040141937 Surfactant-containing cosmetic, dermatological and pharmaceutical agents |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2509232A1 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438968A1 Topical compositions containing at least one polypeptide hydrolase with an amidasic activity and /or compounds capable of modulating this activity |
| 07/21/2004 | EP1438964A1 Process for producing collagen production enhancers and use thereof |
| 07/21/2004 | EP1438954A1 Improvement of thermal stability and flow characteristics of compositions containing chitosan |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 07/21/2004 | EP1438303A2 Flavonoid compounds and their pharmaceutical uses |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438103A1 Betaine-containing cosmetics |
| 07/21/2004 | EP1438073A2 Polyoxyalkylenes conjugates as enzyme inhibitors |
| 07/21/2004 | EP1438069A1 Enzyme inhibitors for inactivating allergens |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438015A2 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 07/21/2004 | EP1438014A2 Oil-in-water emulsion containing non-polar active principles |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1131316B1 Improved chemical process and pharmaceutical formulation |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1514712A Nial Compositions and methods of administering same |
| 07/21/2004 | CN1513839A Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation |
| 07/21/2004 | CN1513557A Compound cortex steroid medicinal composition |
| 07/21/2004 | CN1513543A Gel agent for treating acne and its preparation method |
| 07/21/2004 | CN1513530A Chinese medicine for treating ashen nail and its preparation method |
| 07/21/2004 | CN1513528A Leucoderma treating |
| 07/21/2004 | CN1513521A External use medicine for treating AIDS virus |
| 07/21/2004 | CN1513515A Medicine for treating dermatosis and its preparation method |
| 07/21/2004 | CN1513482A Extraction of Malassezia for treating chlosma, said prepn. and its prepn. method and application thereof |
| 07/21/2004 | CN1513476A Skin-care medicine with functions of relieving-itching, fully eliminating-toxins and curing-tinea, and its prepn. method |
| 07/21/2004 | CN1513460A Spreader cong. compound Triamcinolone acetate, and its prepn. method |
| 07/21/2004 | CN1513458A Compound silver zinc sulfapyrimidine ointment, and its prepn. method |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158106C Application of thymosin alpha 1 in preparation of medicine for curing burn and scald |
| 07/21/2004 | CN1158104C Chinese medicine preparation for treating acute condyloma |
| 07/21/2004 | CN1158090C Medicine for treating psoriasis |
| 07/21/2004 | CN1158069C Antibacterial oil-in-water emulsions |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765001 Mixture with penetration intensifiers, solvents and emulsifiers |